Journal
CANCERS
Volume 10, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/cancers10060199
Keywords
TGF-beta; cancer; immunosuppression; TAK1; mechanobiology; extracellular matrix; tensegrity; DNA damage
Categories
Funding
- District of Columbia Center for AIDS Research
- NIH [AI117970]
- NIAID
- NCI
- NICHD
- NHLBI
- NIDA
- NIMH
- NIA
- FIC
- NIGMS
- NIDDK
- OAR
- UCLA AIDS Institute
- UCLA CFAR NIH [AI-28697]
- James B. Pendleton Charitable Trust
- McCarthy Family Foundation
- NIH
Ask authors/readers for more resources
Transforming growth factor beta (TGF-beta) signaling transduces immunosuppressive biochemical and mechanical signals in the tumor microenvironment. In addition to canonical SMAD transcription factor signaling, TGF-beta can promote tumor growth and survival by inhibiting proinflammatory signaling and extracellular matrix (ECM) remodeling. In this article, we review how TGF-beta activated kinase 1 (TAK1) activation lies at the intersection of proinflammatory signaling by immune receptors and anti-inflammatory signaling by TGF-beta receptors. Additionally, we discuss the role of TGF-beta in the mechanobiology of cancer. Understanding how TGF-beta dampens proinflammatory responses and induces pro-survival mechanical signals throughout cancer development is critical for designing therapeutics that inhibit tumor progression while bolstering the immune response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available